Osteoporosis Drug Denosumab Shows Benefit to 8 YearsOsteoporosis Drug Denosumab Shows Benefit to 8 Years

The FREEDOM Extension study shows a prolonged effect of treatment with the osteoporosis drug denosumab out to 8 years of therapy, albeit with caveats that could explain some of these findings. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news